Neurovia Overview
- Year Founded
-
2013

- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Neurovia General Information
Description
Developer of therapies designed to offer treatment for neurological disorders. The company's therapies have developed a selective thyromimetic agent for the treatment of X-linked adrenoleukodystrophy, enabling X-ALD patients to get treatment for their rare genetic disease.
Contact Information
Website
www.neurovia-inc.comCorporate Office
- 1700 Owens Street
- Suite 525
- San Francisco, CA 94158
- United States
Corporate Office
- 1700 Owens Street
- Suite 525
- San Francisco, CA 94158
- United States
Neurovia Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 01-Nov-2018 | Completed | Out of Business | |||
1. Early Stage VC (Series A) | 25-May-2017 | Completed | Clinical Trials - Phase 1 |
Neurovia Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A |
Neurovia Comparisons
Industry
Financing
Details
Neurovia Competitors (15)
One of Neurovia’s 15 competitors is Biorchestra, a Venture Capital-Backed company based in Daejeon, South Korea.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Biorchestra | Venture Capital-Backed | Daejeon, South Korea | ||||
Neurocrine Biosciences | Formerly VC-backed | San Diego, CA | ||||
Lineage Cell Therapeutics | Corporation | Carlsbad, CA | ||||
Regulus Therapeutics | Pending Transaction (M&A) | San Diego, CA | ||||
Voyager Therapeutics | Corporation | Lexington, MA |
Neurovia FAQs
-
When was Neurovia founded?
Neurovia was founded in 2013.
-
Where is Neurovia headquartered?
Neurovia is headquartered in San Francisco, CA.
-
What industry is Neurovia in?
Neurovia’s primary industry is Biotechnology.
-
Is Neurovia a private or public company?
Neurovia is a Private company.
-
What is Neurovia’s current revenue?
The current revenue for Neurovia is
. -
How much funding has Neurovia raised over time?
Neurovia has raised $13.9M.
-
Who are Neurovia’s competitors?
Biorchestra, Neurocrine Biosciences, Lineage Cell Therapeutics, Regulus Therapeutics, and Voyager Therapeutics are some of the 15 competitors of Neurovia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »